Welcome international healthcare professionals

This site is no longer supported and will not be updated with new content. You are welcome to browse and download all content already included in the site. Please note you will have to register your email address to access the site.

You are here

Melanoma Bridge 2014 3 – 6 December 2014

Melanoma Bridge – jointly organized by Istituto Nazionale Tumori Fondazione "G. Pascale", Fondazione Melanoma Onlus and Sidra Medical and Research Center, together with the Society for ImmunoTherapy of Cancer (SITC) – aims at achieving a broad-based participation by various groups and societies sharing a clinical or basic interest in the immunology and the biology of the cancer microenvironment.

  • Combination Therapies, chair: Paolo A. Ascierto, Giuseppe Palmieri


    • Melanoma Clinical Trials and Real World Experience
    • Beyond BRAFi/MEKi: Combination and sequencing
    • Novel combination therapies for BRAF-mutant
    • Combining targeted drugs and immunotherapy for melanoma
    • Combination therapies based on PD-1/PDL-1 pathway antagonists
    • Strategies and designs for combination immune therapy
    • Combining radiation therapy with immunotherapy: clinical translation
    • Surgery in the combination therapies era
    • coBRIM
  • News in Immunotherapy, chair:  Claus Garbe, Alessandro Testori


    • Grp94-specific monoclonal antibody
    • Myeloid derived suppressor cells
    • Targeting Multiple inhibitory receptors
    • Role of Signal transduction
    • Advances in adoptive cellular therapy
    • Randomized controlled comparison of pembrolizumab
    • Nivolumab improved survival vs. dacarbazine





Register to our E-Alert to stay informed of new clinical research and cases published on this platform.

Featured videos

Watch the videos from Reinhard Dummer, Dirk Schadendorf, Veronique del Marmol and Christian Blank.

Search this site

Search form